全球細胞生存力測定市場規模、佔有率和成長分析：按產品、按應用、按最終用戶、按地區 - 產業預測 (2024-2031)

2022年，全球細胞生存力檢測市場規模為 13.8億美元，預計從2023年的15.2億美元成長到2031年的32.4億美元，在預測期內（2024年~2031年）年複合成長率為9.94 %。

由於藥物開發需求的增加以及製藥和生物技術領域的進步，全球細胞生存力測定（CVA）市場經歷顯著成長。細胞生存力是細胞健康的重要指標，受到化學和物理因素（包括毒性因素）的影響。 CVA 是評估細胞對藥物和病原體反應的重要工具，使其成為早期藥物發現的重要組成部分。這些測定有助於評估化合物的效率、毒性和安全性，這對於藥物開發非常重要。隨著製藥業關注新療法和藥物安全性，對細胞生存力測定的需求預計將成長，並進一步擴大其在醫學研究和藥物測試中的應用。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二級/一級資訊來源
• 市場規模估算
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制因素和挑戰
• 波特的分析和影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 案例研究分析
• 客戶和購買標準分析
• PESTEL分析
• 宏觀經濟指標
• 市場吸引力指數

細胞生存力測定市場規模：依產品，年複合成長率（2024-2031）

• 市場概況
• 消耗品
• 裝置

細胞生存力測定市場規模：依應用分類，年複合成長率（2024-2031）

• 市場概況
• 基礎研究
• 幹細胞研究
• 藥物發現與開發
• 臨床/診斷用途
• 其他用途

細胞生存力測定市場規模：依最終用戶分類，年複合成長率（2024-2031）

• 市場概況
• 學術研究所
• 製藥和生物技術公司
• 醫院/診斷實驗室
• 其他最終用戶

細胞生存力測定市場規模及年複合成長率（2024-2031）

• 北美（產品、應用、最終用戶）
  • 美國
  • 加拿大
• 歐洲（產品、應用程式、最終用戶）
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家
• 亞太地區（產品、應用、最終用戶）
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲（產品、應用、最終用戶）
  • 巴西
  • 其他拉丁美洲
• 中東、非洲（產品、應用程式、最終用戶）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• F. Hoffmann-La Roche AG
• Danaher Corporation
• Lonza Group AG
• Promega Corporation
• Charles River Laboratories International, Inc.
• Menarini Silicon Biosystems, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Macrogen Inc
• DiscoverX Corporation
• Corning Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Perkinelmer, Inc.
• Biognosys
• Cell Signaling Technology, Inc.
• Lebermuth, Inc.
• Eurofins DiscoverX Products
• GE Healthcare
• Beckman Coulter,Inc.

結論和建議

Global Cell Viability Assays Market size was valued at USD 1.38 Billion in 2022 and is poised to grow from USD 1.52 Billion in 2023 to USD 3.24 Billion by 2031, growing at a CAGR of 9.94% in the forecast period (2024-2031).

The global Cell Viability Assays (CVA) market is witnessing significant growth, driven by the increasing demand for drug development and advancements in the pharmaceutical and biotechnology sectors. Cell viability, a critical indicator of cell health, is affected by chemical or physical agents, including toxicity factors. CVAs are essential tools for assessing cellular responses to drugs or pathogens, making them indispensable in early-stage drug discovery. These assays help evaluate compound efficiency, toxicity, and safety profiles, which are vital for drug development. As the pharmaceutical industry focuses on novel therapies and drug safety, the demand for cell viability assays is expected to grow, further expanding their applications in medical research and drug testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Viability Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Viability Assays Market Segmental Analysis

Global Cell Viability Assays Market is segmented by Product, application, end user and region. Based on Product, the market is segmented into Consumables, Instruments. Based on application, the market is segmented into Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications. Based on end user, the market is segmented into Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Viability Assays Market

The continuous investment in research and development by manufacturers to introduce new drugs for treating various conditions is a significant driver in the global Cell Viability Assays market. The pharmaceutical and biotechnology industries heavily rely on cell viability assays for critical processes such as drug discovery, toxicity testing, and evaluating drug efficiency. This ongoing development and innovation within these sectors are driving the growing demand for advanced assays, as they play a crucial role in ensuring the safety and efficacy of new therapeutics. As these industries expand, the need for more precise and reliable assays continues to rise, further fueling market growth.

Restraints in the Global Cell Viability Assays Market

The global Cell Viability Assays market faces significant restraints due to strict regulations on the use of reagents, which impede market growth. Additionally, the high cost of necessary instruments further limits expansion. Certain cell-based assays require specific reagents, such as antibodies, growth factors, cytokines, or fluorescent dyes, to detect and measure cellular responses. These specialized reagents often face limitations due to intellectual property rights, licensing agreements, or limited commercial availability, further hindering market development. As a result, the combination of regulatory restrictions and high costs of both reagents and instruments presents a substantial challenge to the growth of the cell viability assay market.

Market Trends of the Global Cell Viability Assays Market

Continuous innovation in the characteristics of cell viability assays is driving the growth of the global market. Manufacturers are increasingly integrating these assays with emerging technologies such as artificial intelligence (AI) and machine learning, significantly enhancing data analysis, interpretation, and overall assay performance. These advancements not only improve the accuracy and efficiency of cell viability testing but also contribute to more reliable and faster results, which is fostering the growth of the market. As these technologies evolve, the demand for advanced, high-performance cell viability assays continues to rise, further accelerating market expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index

Global Cell Viability Assays Market Size byProduct & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments

Global Cell Viability Assays Market Size byApplication & CAGR (2024-2031)

• Market Overview
• Basic Research
• Stem Cell Research
• Drug Discovery & Development
• Clinical & Diagnostic Applications
• Other Applications

Global Cell Viability Assays Market Size by End User & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End Users

Global Cell Viability Assays Market Size & CAGR (2024-2031)

• North America, (Product, Application, End User)
  • US
  • Canada
• Europe, (Product, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiscoverX Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perkinelmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biognosys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lebermuth, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter,Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation